← Leaderboards
Anil K Malhotra
Long Island Jewish Medical Center
$14,850,627
Attributed
$15,096,303
Total exposure
23
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,525,227 · 24
By mechanism
R01$12,071,434 · 6
P50$9,693,849 · 2
K23$621,387 · 1
P30$374,201 · 1
R61$368,514 · 1
M01$257,717 · 12
Top collaborators
- Robert W Buchanan1 shared
- Aristotle Nicholas Voineskos1 shared
Most similar at Long Island Jewish Medical Center
Same institution · by research overlap
- John M Kane$49,583,682
- Delbert G Robinson$11,665,634
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaBaseResponseAntipsychotic AgentsSymptomsResearch PersonnelResourcesDesignHospitalsFundingGeneticTreatment ResponsePharmacogeneticsPharmaceutical PreparationsStructureFunctional DisabilityAdverse EffectsNeuroimagingImpaired CognitionCohortGenotypeFunctional DisorderFunctional OutcomesMediating
Grant awards (68)
2/5-Biomarkers to Enhance Early Schizophrenia Treatment (BEEST)$630,879
R01 · FY2025 · MH · contact PI
2/5-Biomarkers to Enhance Early Schizophrenia Treatment (BEEST)$608,943
R01 · FY2024 · MH · contact PI
Neuromodulation of Social Cognitive Circuitry in People with Schizophrenia Spectrum Disorders$368,514
R61 · FY2022 · MH
Connectivity Biomarkers of Clinical Response in Treatment Resistant Schizophrenia$692,366
R01 · FY2021 · MH · contact PI
Striatal Connectivity and Clinical Outcome in Psychosis$137,384
R01 · FY2021 · MH · contact PI
Connectivity Biomarkers of Clinical Response in Treatment Resistant Schizophrenia$692,366
R01 · FY2020 · MH · contact PI
Striatal Connectivity and Clinical Outcome in Psychosis$504,299
R01 · FY2020 · MH · contact PI
Connectivity Biomarkers of Clinical Response in Treatment Resistant Schizophrenia$576,119
R01 · FY2019 · MH · contact PI
Striatal Connectivity and Clinical Outcome in Psychosis$525,461
R01 · FY2019 · MH · contact PI
Connectivity Biomarkers of Clinical Response in Treatment Resistant Schizophrenia$692,366
R01 · FY2018 · MH · contact PI
Striatal Connectivity and Clinical Outcome in Psychosis$525,461
R01 · FY2018 · MH · contact PI
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)$337,000
R01 · FY2018 · MH · contact PI
Connectivity Biomarkers of Clinical Response in Treatment Resistant Schizophrenia$728,807
R01 · FY2017 · MH · contact PI
Striatal Connectivity and Clinical Outcome in Psychosis$525,461
R01 · FY2017 · MH · contact PI
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)$379,125
R01 · FY2017 · MH · contact PI
Striatal Connectivity and Clinical Outcome in Psychosis$563,310
R01 · FY2016 · MH · contact PI
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)$379,125
R01 · FY2016 · MH · contact PI
2/2-Pramipexole in Bipolar Disorder: Targeting Cognition$294,875
R01 · FY2016 · MH · contact PI
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)$379,125
R01 · FY2015 · MH · contact PI
2/2-Pramipexole in Bipolar Disorder: Targeting Cognition$294,875
R01 · FY2015 · MH · contact PI
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)$72,656
R01 · FY2015 · MH · contact PI
2/3-Social Processes Initiative in Neurobiology of the Schizophrenia(s)$376,728
R01 · FY2014 · MH · contact PI
2/2-Pramipexole in Bipolar Disorder: Targeting Cognition$294,875
R01 · FY2014 · MH · contact PI
Biomarkers Unit (Research Methods Core)$73,090
P30 · FY2014 · MH · contact PI
The Ninth Annual Pharmacogenetics in Psychiatry Meeting$46,041
R13 · FY2014 · MH · contact PI
Biomarkers Unit (Research Methods Core)$73,343
P30 · FY2013 · MH · contact PI
The Ninth Annual Pharmacogenetics in Psychiatry Meeting$1
R13 · FY2013 · MH · contact PI
Dissecting Heterogeneity of Treatment Response of First Episode Schizophrenia$1,819,702
P50 · FY2012 · MH · contact PI
Dissecting Heterogeneity of Treatment Response of First Episode Schizophrenia$553,557
P50 · FY2012 · MH · contact PI
Dissecting Heterogeneity of Treatment Response of First Episode Schizophrenia$256,070
P50 · FY2012 · MH · contact PI
Pharmacogenomics of treatment response in first episode schizophrenia$195,988
P50 · FY2012 · MH · contact PI
Pharmacogenomics of treatment response in first episode schizophrenia$79,079
P50 · FY2012 · MH · contact PI
Biomarkers Unit (Research Methods Core)$70,791
P30 · FY2012 · MH · contact PI
The Ninth Annual Pharmacogenetics in Psychiatry Meeting$46,041
R13 · FY2012 · MH · contact PI
Pharmacogenomics of treatment response in first episode schizophrenia$36,581
P50 · FY2012 · MH · contact PI
Biomarkers Unit (Research Methods Core)$18,320
P30 · FY2012 · MH · contact PI
Dissecting Heterogeneity of Treatment Response of First Episode Schizophrenia$1,895,229
P50 · FY2011 · MH · contact PI
Genetic Variation and Functional Disability in Schizophrenia$369,765
R01 · FY2011 · MH · contact PI
Pharmacogenomics of treatment response in first episode schizophrenia$239,577
P50 · FY2011 · MH · contact PI
Biomarkers Unit (Research Methods Core)$69,697
P30 · FY2011 · MH · contact PI
The Ninth Annual Pharmacogenetics in Psychiatry Meeting$1
R13 · FY2011 · MH · contact PI
Dissecting Heterogeneity of Treatment Response of First Episode Schizophrenia$1,918,337
P50 · FY2010 · MH · contact PI
Genetic Variation and Functional Disability in Schizophrenia$373,500
R01 · FY2010 · MH · contact PI
Pharmacogenomics of treatment response in first episode schizophrenia$241,551
P50 · FY2010 · MH · contact PI
INITIAL SCREENING FOR HEALTHY VOLUNTEERS$70,371
M01 · FY2010 · RR · contact PI
Biomarkers Unit (Research Methods Core)$68,960
P30 · FY2010 · MH · contact PI
GENETIC VARIATION AND FUNCTIONAL DISABILITY IN SCHIZOPHRENIA$53,414
M01 · FY2010 · RR · contact PI
The Ninth Annual Pharmacogenetics in Psychiatry Meeting$46,041
R13 · FY2010 · MH · contact PI
CYTOCHROME P450 GENOTYPING AND CLINICAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA$6,782
M01 · FY2010 · RR · contact PI
CEREBROSPINAL FLUID BIOMARKERS OF PSYCHIATRIC DISORDERS$4,239
M01 · FY2010 · RR · contact PI
GENETICS OF THE EARLY ONSET OF PSYCHIATRIC DISORDERS$848
M01 · FY2010 · RR · contact PI
Dissecting Heterogeneity of Treatment Response of First Episode Schizophrenia$1,986,029
P50 · FY2009 · MH · contact PI
Genetic Variation and Functional Disability in Schizophrenia$373,500
R01 · FY2009 · MH · contact PI
Pharmacogenomics of treatment response in first episode schizophrenia$238,668
P50 · FY2009 · MH · contact PI
GENETIC VARIATION AND FUNCTIONAL DISABILITY IN SCHIZOPHRENIA$14,247
M01 · FY2009 · RR · contact PI
INITIAL SCREENING AT HILLSIDE AS A HEALTHY VOLUNTEER$11,901
M01 · FY2009 · RR · contact PI
GENETICS OF THE EARLY ONSET OF PSYCHIATRIC DISORDERS$7,207
M01 · FY2009 · RR · contact PI
D-SERINE TREATMENT OF SCHIZOPHRENIA$2,682
M01 · FY2009 · RR · contact PI
Genetic Variation and Functional Disability in Schizophrenia$371,813
R01 · FY2008 · MH · contact PI
Pharmacogenomics of treatment response in first episode schizophrenia$233,481
P50 · FY2008 · MH · contact PI
D-SERINE TREATMENT OF SCHIZOPHRENIA$60,772
M01 · FY2008 · RR · contact PI
GENETICS OF THE EARLY ONSET OF PSYCHIATRIC DISORDERS$18,417
M01 · FY2008 · RR · contact PI
Genetic Variation and Functional Disability in Schizophrenia$371,250
R01 · FY2007 · MH · contact PI
D-SERINE TREATMENT OF SCHIZOPHRENIA$6,837
M01 · FY2007 · RR · contact PI
CLINICAL TRIALS IN SCHIZOPHRENIA--MOLECULAR APPROACHES$151,613
K23 · FY2003 · MH
CLINICAL TRIALS IN SCHIZOPHRENIA--MOLECULAR APPROACHES$157,242
K23 · FY2002 · MH
CLINICAL TRIALS IN SCHIZOPHRENIA--MOLECULAR APPROACHES$156,650
K23 · FY2001 · MH
CLINICAL TRIALS IN SCHIZOPHRENIA--MOLECULAR APPROACHES$155,882
K23 · FY2000 · MH